1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors
申请人:Swinnen Dominique
公开号:US20090029903A1
公开(公告)日:2009-01-29
The present invention is related to carboxylic acids of Formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of carboxylic acids of Formula (I) to modulate, notably to inhibit the activity of PTPs.
1,1'-(1,2-ETHYNEDIYL)BIS-BENZENE DERIVATIVES AS PTP 1-B INHIBITORS
申请人:Applied Research Systems ARS Holding N.V.
公开号:EP1756081A1
公开(公告)日:2007-02-28
US7947851B2
申请人:——
公开号:US7947851B2
公开(公告)日:2011-05-24
[EN] 1,1'-(1,2-ETHYNEDIYL)BIS-BENZENE DERIVATIVES AS PTP 1-B INHIBITORS<br/>[FR] DERIVES DE 1,1'-(1,2-ETHYNEDIYLE)BIS-BENZENE INHIBITEURS DE PTP 1-B
申请人:APPLIED RESEARCH SYSTEMS
公开号:WO2005097773A1
公开(公告)日:2005-10-20
The present invention is related to carboxylic acids of Formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of carboxylic acids of Formula (I) to modulate, notably to inhibit the activity of PTPs.